Opioid Treatment and Peer Recovery Support

NCT04978168 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 450

Last updated 2025-05-13

No results posted yet for this study

Summary

Determine whether a facilitated local change team intervention improves a probation organization's client-level medication for opioid use disorder (MOUD) outcomes and implementation outcomes relative to baseline across multiple sites. Determine whether client-level outcomes are further enhanced by the introduction of Peer Support Services.

Conditions

  • Opioid-use Disorder

Interventions

BEHAVIORAL

Core Intervention

Staff are provided with a core set of implementation strategies to facilitate interorganizational linkages between probation agencies and local community treatment providers.

BEHAVIORAL

Peer Support Specialists (PSS)

Participants randomized to PSS will meet with a PSS for 6 months. Contact scheduled is flexible and based on the participant's needs and wants, plus written guidance for PSS-participant interactions.

BEHAVIORAL

Treatment as Usual (TAU)

Participants randomized to TAU will receive the services that will be offered at the time the Core Implementation intervention is completed.

Sponsors & Collaborators

  • University of North Carolina, Chapel Hill

    collaborator OTHER
  • Temple University

    collaborator OTHER
  • University of Rhode Island

    collaborator OTHER
  • The Miriam Hospital

    collaborator OTHER
  • National Institute on Drug Abuse (NIDA)

    collaborator NIH
  • CODAC Behavioral Healthcare

    collaborator UNKNOWN
  • Duke University

    collaborator OTHER
  • Brown University

    lead OTHER

Principal Investigators

  • Rosemarie A Martin, PhD · Brown University

  • Damaris J Rohsenow, PhD · Brown University

  • Lauren Brinkley-Rubinstein, PhD · Duke University

  • Steven Belenko, PhD · Temple University

  • Lynda Stein, PhD · University of Rhode Island

  • Josiah Rich, MD · The Miriam Hospital

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-02
Primary Completion
2025-12-30
Completion
2026-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04978168 on ClinicalTrials.gov